The purpose of this topical preparation is to provide targeted, symptomatic support across several domains driven by superficial vascular and traumatic events. It is primarily applied to help ease the overall burden of symptoms, offering relief when manifestations become noticeable and interfere with comfort.

The preparation is intended to help address symptoms related to localized bruising, swelling, and superficial inflammation of the veins.

---

This gel is used in situations involving symptoms related to physical discomfort linked to minor, localized superficial vein issues, including feelings of heaviness, tightness, and generalized aching. It is also relevant for managing superficial bruising (hematomas) and local edema (swelling) that arise from minor impacts or circulatory stasis.

“The application of this supportive treatment is primarily relevant when symptoms create noticeable physiological strain, providing supportive relief when symptoms interfere with routine activities.”

---

Quick Fact: Symptomatic Support Domains

Symptom Domain	Key Benefit
Vascular Tension	Contributes to easing the overall symptom load associated with heaviness.
Bruising/Impact	Helps maintain a sense of stability when symptoms are more noticeable, assisting with tenderness.
Localized Edema	Supports general well-being during symptomatic phases and is relevant for easing swelling.

Regulatory References

1. SingHealth, a prominent public healthcare group

The eligibility for using topical preparations like Thrombocid Gel, which contains Pentosan Polysulfate Sodium (PPS), is defined by official regulatory documentation to ensure appropriate population-based use.

Eligibility Scope

Status	Population or Condition	Regulatory Classification
Contraindicated	Known Hypersensitivity to PPS or excipients	Absolute prohibition
	Active Pathological Bleeding	Absolute prohibition
Conditional Use	Patients with increased risk of bleeding (e.g., thrombocytopenia)	Use with Caution/Monitoring
	Hepatic or Renal Impairment	Use with Caution/Monitoring
Not Recommended	Pediatric Population (Children & Adolescents)	Safety/Efficacy Not Established
	Pregnancy and Breastfeeding	Caution / Use Not Recommended

Eligibility Classifications (Official Regulatory Basis)

Official labeling primarily allows use in the Adult Population for the labeled superficial indications. Use is contraindicated for patients with a documented hypersensitivity or the presence of active pathological bleeding due to the weak anticoagulant properties of PPS. The medication’s use in the pediatric population is not established as the necessary safety and efficacy studies have not been performed.

Official Eligibility Statements

• The gel is contraindicated in individuals with a known allergy to any component of the formulation.
• Use is not recommended in children and adolescents, as safety data are insufficient.
• Use during pregnancy and breastfeeding requires caution, and is generally not recommended unless necessary.
• Conditional use is mandated for patients with hepatic or renal impairment or pre-existing conditions that increase the risk of hemorrhage.

Thrombocid Gel's active ingredient, pentosan polysulfate sodium, is a low-molecular-weight, heparin-like substance with local anticoagulant and fibrinolytic effects. Because this medication is applied topically to the skin for local action, the risk of systemic absorption reaching levels high enough to cause drug-drug interactions is generally considered low.

However, it is a recommended precaution, especially when applying the gel to large areas, that patients inform their healthcare provider or pharmacist if they are taking other medicines that affect blood clotting. Concomitant use with other agents that also have antiplatelet or anticoagulant properties may theoretically increase the risk of localized bleeding or bruising, though the extent of this risk with topical application is not fully established.

Potential Interaction Considerations

Type of Concomitant Drug	Precaution
Oral Anticoagulants (e.g., warfarin)	Use with caution, especially if applied to large areas or for extended periods.
Antiplatelet Agents (e.g., aspirin, clopidogrel)	Monitor for increased local bruising or bleeding.
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)	Use cautiously due to shared risk of bleeding.

Inform your doctor or pharmacist about all medications, supplements, and herbal products you are using before starting treatment with Thrombocid Gel. The gel should also not be applied to open wounds, mucous membranes, or areas of active bleeding.

The active component of Thrombocid Gel modulates the endogenous coagulation cascade at the local tissue level. The molecular structure facilitates transdermal penetration, allowing the compound to reach local tissue sites where the target enzymes are expressed.

The primary pharmacodynamic mechanism involves the direct inhibition of Factor Xa (FXa), a serine protease enzyme positioned within the final common pathway of the coagulation cascade. Inhibition of this enzyme reduces the conversion of prothrombin to thrombin. Furthermore, the compound modulates the activity of activated Protein C, promoting the enzymatic degradation of the cofactors Factors Va and VIIIa. This dual action on the intrinsic and extrinsic pathways results in a reduction in the overall enzymatic generation of thrombin, thereby modulating the fibrin formation process.

How to Use Thrombocid Gel: Administration Guidelines

Thrombocid Gel, a topical preparation containing 15 mg/g of Sodium Pentosan Polysulfate, follows specific administration parameters. The protocol is centered on topical (cutaneous) application and defines parameters for dosing, frequency, and application technique.

---

Administration Scope

The route is topical application only, where the gel is applied directly to the affected skin area. The dose is defined by the length of the dispensed product: a strip of gel measuring approximately 5 cm to 15 cm, which should correlate with the size of the area being addressed. The preparation is for use in adults, the elderly, and children over 5 years of age.

---

Dosing Schedule and Procedural Rules

The gel is typically applied once or several times a day, with administration frequency generally limited to a maximum of three to four times daily. When applying the product, instructions specify that it must be spread as a thin layer and is not required to be rubbed in. Furthermore, the protocol specifies that the gel must not be applied to exposed wounds, broken skin, or mucous membranes, as this product is intended only for application to intact skin.

This regimen can be used for long-term treatments when necessary. These instructions establish a standardized pattern for the use of the product.

Research Evidence / Overview of Studies for Thrombocid Gel

The evidence base for this topical preparation, whose active component is Pentosan Polysulfate Sodium, comes from clinical research exploring how symptoms change over time across several related vascular and traumatic conditions. The research provides context regarding patterns that have been observed so far in formal study settings, contributing to the broader evidence landscape for conditions where symptoms may vary in intensity.

---

Evidence for use in Superficial Venous Thrombosis (STP) and Superficial Thrombophlebitis (SVT)

Research has explored the topical application of this class of medicine in short-term Randomized Controlled Trials (RCTs) and Systematic Reviews. These studies evaluated patient groups presenting with symptoms consistent with acute or disruptive episodes, such as inflammation of superficial veins. The studies monitored measured outcomes, including the level of pain intensity, the amount of local swelling (edema), and the physical manifestations of redness and tissue hardening at the site of the affected vein. Studies report how symptoms evolved in the observed populations over defined time intervals.

---

Evidence for Symptoms Associated with Chronic Venous Disorders

This preparation was also evaluated in studies examining patient-reported experiences related to chronic conditions where symptoms, such as heaviness and aching in the legs, may vary in intensity. Clinical trials monitored patient-reported outcomes describing perceived discomfort, with researchers assessing scores for symptoms like leg heaviness and tightness, alongside metrics related to the overall Quality of Life (QoL). Findings contribute to the understanding of how patients reported their experience when symptoms become more noticeable.

---

Evidence Quality, Limitations, and Research Gaps

The available evidence base is characterized by several important research limitation frames that affect interpretation. The evidence quality varies across studies, and systematic analysis of the literature highlights methodological inconsistencies and the use of outdated protocols. Long-term effects are not fully established, as follow-up durations were limited in most core clinical studies. The research does not determine whether an individual will respond similarly to the group patterns observed in the studies, and findings describe group patterns, not personal outcomes.

Key Studies & References

1. A Comparative Study on the Efficacy of Heparin Ointment and Hirudoid Cream on Treatment of Thrombophlebitis Resulted From Intravenous Catheter Insertion and Multidrug Infusion
2. WHO Anatomical Therapeutic Chemical (ATC) Classification C05BA04 (Pentosan Polysulfate)

Common questions about Thrombocid Gel (FAQ)

---

Q: How quickly should I expect to see an effect after applying the gel?

A: Official patient information advises that a healthcare professional should be consulted if the symptoms worsen or show no sign of improvement after 5 days of treatment. This timeframe reflects the period during which the product is generally used for self-treatment before consulting a healthcare professional is advised.

---

Q: How long does the effect of one application of Thrombocid Gel last?

A: The expected duration of the gel's action is reflected in the official administration instructions. The repetition of application throughout the day is consistent with maintaining the compound's effect on the affected area.

---

Q: How often can people generally apply Thrombocid Gel?

A: Regulatory documents define the administration frequency as 3 or 4 times a day. This schedule is outlined in the official instructions for use.

---

Q: Can the gel be used under a compression bandage?

A: Official information states that the application of Thrombocid Gel does not typically require a dressing. However, official product information suggests covering the preparation with a gauze or compress is permitted, if necessary.

---

Q: What is the maximum duration this gel is typically used for?

A: Official labeling states the regimen is suitable for long-term use. For acute issues, professional medical advice is advised if symptoms do not show improvement after 5 days.

---

Q: How do medical professionals describe the active ingredient's role?

A: The active ingredient, Sodium Pentosan Polysulfate, is officially classified as a topical heparinoid and a topical antivaricose agent. Its role is defined as promoting localized blood circulation and modulating the formation of minute blood components at the site of application.

---

Q: Is Thrombocid Gel the same as other heparinoid creams?

A: Thrombocid Gel is officially classified as a topical heparinoid preparation. This means it belongs to the same general pharmacological group as other medicines that share a similar composition and are used for related indications on the skin.

---

Q: Does Thrombocid Gel help with swelling?

A: Official regulatory information describes the active component as having an antiphlogistic (anti-inflammatory) effect. This action is noted to limit local fluid accumulation, which relates to swelling in the affected tissues.

---

Q: Are there different strengths of Thrombocid Gel?

A: Official product labeling confirms that the product line includes various strengths of the active ingredient. These typically include concentrations such as 1 mg/g, 5 mg/g (often called Forte), and the 15 mg/g Gel.

---

Q: What does 'venous disorders' mean in the context of this gel?

A: In the context of the gel's authorized uses, 'superficial venous disorders' refers to localized symptoms. This commonly includes feelings of heaviness, tension, or tightness in the legs that are associated with surface vascular issues like varicose veins (varices) in adults.

---

Q: Why is this gel used for superficial phlebitis?

A: The product is indicated for use as a topical adjuvant therapy for certain complications. This includes use for superficial thrombophlebitis, particularly when it occurs following injectable treatments.

---

Q: Can the gel be used on the face?

A: Regulatory information includes specific cautions regarding application to the face, noting that the skin is more sensitive to certain excipients. Official documents also caution against using the product on the skin around the eyes.

---

Q: What is the risk of skin rash from Thrombocid Gel?

A: The risk of side effects like rash or contact dermatitis is documented in official safety sections. These reactions are typically classified as 'very rarely' (less than 1 in 10,000 patients) or as having a 'Not Known' frequency, meaning the exact rate cannot be estimated from available data.

---

Q: Are there any common skin care ingredients that should not be used with Thrombocid Gel?

A: Official instructions advise against applying any other topical preparations to the same area of the skin as the gel. This is based on the general caution that concurrent use may affect the intended function or absorption of the gel.

---

Q: Can Thrombocid Gel be used for muscle soreness?

A: The official indications include use for symptoms related to mild to moderate muscle discomfort and post-traumatic pain in some regions. This application is consistent with the product's classification as a local antiphlogistic agent.

---

Q: Does this gel contain parabens or alcohol?

A: The list of excipients (non-active ingredients) confirms the presence of both alcohols (e.g., cetearyl alcohol) and parahydroxybenzoates, which are a type of paraben. These components are used to stabilize the gel but are noted on the official label.

---

Q: Can people use this gel for varicose veins?

A: The product is indicated for the local symptomatic relief of superficial venous disorders. This includes addressing the associated heaviness and tightness experienced in the legs due to conditions like varicose veins (varices).

---

Q: Is it normal if my skin feels itchy after using the gel for several days?

A: Itching at the application site has been reported as a very rare allergic reaction in official safety documents. If signs of a persistent reaction such as itching or rash occur, regulatory guidance suggests discontinuing the product.

---

Q: What countries is Thrombocid Gel approved for use in?

A: The regulatory documents for this specific product, including official patient information leaflets, originate from governmental health agencies in various countries, such as Spain, Portugal, and Malta, indicating its approval within those regions.

---

Q: Do you need to rub the gel in completely or just apply it?

A: Official instructions indicate that the preparation is to be applied with gentle massaging to support the penetration of the active ingredients. This method helps to work the gel into the affected area.

---

Q: Does Thrombocid Gel have a strong odor?

A: The product's composition is a combination that includes three essential oils: Melissa Oil, Pumilio Pine Oil, and Rosemary Oil. These ingredients naturally contribute a distinct scent to the finished gel product.

Storage and Disposal of Thrombocid Gel

Storage and disposal requirements for Thrombocid Gel are based on official regulatory guidelines to maintain product stability and ensure safety.

Storage Conditions

Constraint	Requirement
Temperature	Store below 30°C and protect from excess heat.
Environment	Must be kept in a cool, dry place and protected from freezing and direct light.
Container	Keep the product in its original container, tightly closed.

Child-Safety and Disposal

The gel must be stored strictly out of the sight and reach of children.

For disposal of unused or expired product, the official guidance is to use drug take-back programs or, if unavailable, follow the approved household trash procedure by mixing the gel with an undesirable substance, then sealing and discarding it. Do not flush the medication down the toilet or pour it down a drain.